NxGen MDx Revenue and Competitors
Estimated Revenue & Valuation
- NxGen MDx's estimated annual revenue is currently $24M per year.
- NxGen MDx's estimated revenue per employee is $270,000
Employee Data
- NxGen MDx has 89 Employees.
- NxGen MDx grew their employee count by -13% last year.
NxGen MDx's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP Operations | Reveal Email/Phone |
3 | VP Corporate Affairs | Reveal Email/Phone |
4 | VP Sales | Reveal Email/Phone |
5 | Director New Account Development, East Region Manager | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Business Development Manager | Reveal Email/Phone |
8 | Business Development Manager | Reveal Email/Phone |
9 | Genetic Counseling Manager | Reveal Email/Phone |
10 | Project Manager and Executive Assistant | Reveal Email/Phone |
NxGen MDx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 32 | 0% | N/A | N/A |
#2 | $161M | 477 | 1% | N/A | N/A |
#3 | $6248.3M | 16530 | 4% | N/A | N/A |
#4 | $6.9M | 32 | 3% | N/A | N/A |
#5 | $71.6M | 241 | -1% | N/A | N/A |
#6 | $173.8M | 515 | 19% | N/A | N/A |
#7 | $51.7M | 174 | -5% | N/A | N/A |
#8 | $18M | 74 | 3% | N/A | N/A |
#9 | $24M | 89 | 10% | N/A | N/A |
#10 | $7.3M | 34 | 6% | N/A | N/A |
What Is NxGen MDx?
The NxGen MDX office and laboratory is centered within Grand Rapids’ prestigious medical corridor to offer our patients the very best and brightest of the genetics field. Known for drawing researchers, scientists and patients from all over the world, this hub of medical knowledge ensures our reliable, advanced methodologies stay ahead of the curve.
keywords:N/AN/A
Total Funding
89
Number of Employees
$24M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 89 | 7% | N/A |
#2 | N/A | 89 | 31% | N/A |
#3 | $21.8M | 89 | 16% | N/A |
#4 | $21.8M | 89 | 24% | N/A |
#5 | $18.7M | 89 | -1% | N/A |